Literature DB >> 19857483

Luteolin promotes long-term potentiation and improves cognitive functions in chronic cerebral hypoperfused rats.

Bei Xu1, Xiao-Xiu Li, Guo-Rong He, Juan-Juan Hu, Xin Mu, Shuo Tian, Guan-Hua Du.   

Abstract

Processes of synaptic plasticity, such as long-term potentiation (LTP), has been considered a cellular correlate of learning and memory and many neurological disorders accompanied by cognitive deficits exhibit abnormal synaptic function. This emerging concept is exemplified by Alzheimer's disease. Mounting evidence suggests that Alzheimer's disease begins with subtle alterations of hippocampal synaptic efficacy prior to frank neuronal degeneration, which make it critical to identify LTP enhancers to slow down or stop the progression of Alzheimer's disease. In this study, we found flavonoid luteolin could enhance basal synaptic transmission and facilitate the induction of LTP by high frequency stimulation in the dental gyrus of rat hippocampus. Furthermore, we investigated the effects of luteolin on chronic cerebral hypoperfusion-induced spatial learning dysfunction and LTP impairment in rat. The results showed chronic cerebral hypoperfusion produced by 2-vessel occlusion significantly impaired spatial learning and memory, and luteolin reversed the learning and memory deficit. 2-vessel occlusion resulted in dramatic inhibition of LTP formation in the hippocampus and luteolin significantly rescued the LTP impairment. These results demonstrate that luteolin not only directly modulates LTP formation, but also protects synapses from the detrimental effects of chronic cerebral hypoperfusion on LTP formation, which may contribute to the protective effects of luteolin on learning and memory. By immunoblotting, we found the effects of luteolin on LTP and memory may due to the activation of cAMP response element-binding protein (CREB). Therefore, flavonoid luteolin shows great potential as a novel treatment agent for protecting synaptic function and enhancing memory in neurodegenerative disorders. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19857483     DOI: 10.1016/j.ejphar.2009.10.038

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

1.  Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism.

Authors:  Bartolomeo Bertolino; Rosalia Crupi; Daniela Impellizzeri; Giuseppe Bruschetta; Marika Cordaro; Rosalba Siracusa; Emanuela Esposito; Salvatore Cuzzocrea
Journal:  CNS Neurosci Ther       Date:  2016-10-04       Impact factor: 5.243

Review 2.  N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.

Authors:  Stephen D Skaper; Laura Facci; Massimo Barbierato; Morena Zusso; Giuseppe Bruschetta; Daniela Impellizzeri; Salvatore Cuzzocrea; Pietro Giusti
Journal:  Mol Neurobiol       Date:  2015-06-09       Impact factor: 5.590

Review 3.  The Flavone Luteolin Improves Central Nervous System Disorders by Different Mechanisms: A Review.

Authors:  Zeinab Ashaari; Mousa-Al-Reza Hadjzadeh; Gholamreza Hassanzadeh; Tahereh Alizamir; Behpour Yousefi; Zakieh Keshavarzi; Tahmineh Mokhtari
Journal:  J Mol Neurosci       Date:  2018-08-06       Impact factor: 3.444

4.  Ocimum sanctum Linn. Extract Improves Cognitive Deficits in Olfactory Bulbectomized Mice via the Enhancement of Central Cholinergic Systems and VEGF Expression.

Authors:  Xoan Thi Le; Hien Thu Nguyen; Tai Van Nguyen; Hang Thi Nguyet Pham; Phuong Thi Nguyen; Khoi Minh Nguyen; Ba Van Nguyen; Kinzo Matsumoto
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-30       Impact factor: 2.629

5.  Natural products as promising drug candidates for the treatment of Alzheimer's disease: molecular mechanism aspect.

Authors:  Niloufar Ansari; Fariba Khodagholi
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

6.  Investigation on the Anticonvulsant Potential of Luteolin and Micronized Luteolin in Adult Zebrafish (Danio rerio).

Authors:  Cristiane Garbinato; Cássia Alves Lima-Rezende; Sabrina Ester Schneider; Jefferson Pedroso; Aline E Dos Santos; Fernanda Petry; Gean Pablo S Aguiar; Liz Girardi Müller; Marcelo Lanza; Angelo Piato; J Vladimir Oliveira; Anna Maria Siebel
Journal:  Neurochem Res       Date:  2021-07-26       Impact factor: 3.996

Review 7.  Flavonoid-Based Nanomedicines in Alzheimer's Disease Therapeutics: Promises Made, a Long Way To Go.

Authors:  Pragya Prasanna; Arun Upadhyay
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-27

8.  Reperfusion does not improve impaired rapid-onset cortical plasticity in patients with severe stenosis of the internal carotid artery.

Authors:  Jonathan List; Johannes Albers; Julia Kürten; Arne Schwindt; Eike Wilbers; Agnes Flöel
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

9.  Luteolin induces microRNA-132 expression and modulates neurite outgrowth in PC12 cells.

Authors:  Lian-Fang Lin; Szu-Ping Chiu; Ming-Jiuan Wu; Pei-Yi Chen; Jui-Hung Yen
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

Review 10.  Neurological effects of honey: current and future prospects.

Authors:  Mohammad Mijanur Rahman; Siew Hua Gan; Md Ibrahim Khalil
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-27       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.